Global Oligonucleotides Supply, Demand and Key Producers, 2024-2030

Description

The global Oligonucleotides market size is expected to reach $ 2461.4 million by 2030, rising at a market growth of 9.7% CAGR during the forecast period (2024-2030).

Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.

North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.

In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

This report studies the global Oligonucleotides demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oligonucleotides, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oligonucleotides that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oligonucleotides total market, 2019-2030, (USD Million)
Global Oligonucleotides total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oligonucleotides total market, key domestic companies and share, (USD Million)
Global Oligonucleotides revenue by player and market share 2019-2024, (USD Million)
Global Oligonucleotides total market by Type, CAGR, 2019-2030, (USD Million)
Global Oligonucleotides total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Oligonucleotides market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript and BBI Life Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oligonucleotides market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oligonucleotides Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oligonucleotides Market, Segmentation by Type
    DNA Oligos
    RNA Oligos

Global Oligonucleotides Market, Segmentation by Application
    Pharmaceutical
    Research
    Diagnostic

Companies Profiled:
    Integrated DNA Technologies
    Agilent
    Sigma-aldrich
    Eurofins Genomics
    L.G.C Biosearch Technologies
    Eurogentec S.A
    Nitto Denko Avecia Inc
    GenScript
    BBI Life Sciences
    GeneDesign
    TriLink BioTechnologies
    SGS DNA
    LC Sciences
    Twist Bioscience
    Creative Biogene
    General Biosystems

Key Questions Answered
1. How big is the global Oligonucleotides market?
2. What is the demand of the global Oligonucleotides market?
3. What is the year over year growth of the global Oligonucleotides market?
4. What is the total value of the global Oligonucleotides market?
5. Who are the major players in the global Oligonucleotides market?

Table of Contents

1 Supply Summary
    1.1 Oligonucleotides Introduction
    1.2 World Oligonucleotides Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Oligonucleotides Total Market by Region (by Headquarter Location)
        1.3.1 World Oligonucleotides Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Oligonucleotides Market Size (2019-2030)
        1.3.3 China Oligonucleotides Market Size (2019-2030)
        1.3.4 Europe Oligonucleotides Market Size (2019-2030)
        1.3.5 Japan Oligonucleotides Market Size (2019-2030)
        1.3.6 South Korea Oligonucleotides Market Size (2019-2030)
        1.3.7 ASEAN Oligonucleotides Market Size (2019-2030)
        1.3.8 India Oligonucleotides Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oligonucleotides Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oligonucleotides Major Market Trends

2 Demand Summary
    2.1 World Oligonucleotides Consumption Value (2019-2030)
    2.2 World Oligonucleotides Consumption Value by Region
        2.2.1 World Oligonucleotides Consumption Value by Region (2019-2024)
        2.2.2 World Oligonucleotides Consumption Value Forecast by Region (2025-2030)
    2.3 United States Oligonucleotides Consumption Value (2019-2030)
    2.4 China Oligonucleotides Consumption Value (2019-2030)
    2.5 Europe Oligonucleotides Consumption Value (2019-2030)
    2.6 Japan Oligonucleotides Consumption Value (2019-2030)
    2.7 South Korea Oligonucleotides Consumption Value (2019-2030)
    2.8 ASEAN Oligonucleotides Consumption Value (2019-2030)
    2.9 India Oligonucleotides Consumption Value (2019-2030)

3 World Oligonucleotides Companies Competitive Analysis
    3.1 World Oligonucleotides Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oligonucleotides Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oligonucleotides in 2023
        3.2.3 Global Concentration Ratios (CR8) for Oligonucleotides in 2023
    3.3 Oligonucleotides Company Evaluation Quadrant
    3.4 Oligonucleotides Market: Overall Company Footprint Analysis
        3.4.1 Oligonucleotides Market: Region Footprint
        3.4.2 Oligonucleotides Market: Company Product Type Footprint
        3.4.3 Oligonucleotides Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oligonucleotides Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oligonucleotides Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Oligonucleotides Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Oligonucleotides Consumption Value Comparison
        4.2.1 United States VS China: Oligonucleotides Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oligonucleotides Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Oligonucleotides Companies and Market Share, 2019-2024
        4.3.1 United States Based Oligonucleotides Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oligonucleotides Revenue, (2019-2024)
    4.4 China Based Companies Oligonucleotides Revenue and Market Share, 2019-2024
        4.4.1 China Based Oligonucleotides Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oligonucleotides Revenue, (2019-2024)
    4.5 Rest of World Based Oligonucleotides Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Oligonucleotides Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oligonucleotides Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Oligonucleotides Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 DNA Oligos
        5.2.2 RNA Oligos
    5.3 Market Segment by Type
        5.3.1 World Oligonucleotides Market Size by Type (2019-2024)
        5.3.2 World Oligonucleotides Market Size by Type (2025-2030)
        5.3.3 World Oligonucleotides Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oligonucleotides Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical
        6.2.2 Research
        6.2.3 Diagnostic
    6.3 Market Segment by Application
        6.3.1 World Oligonucleotides Market Size by Application (2019-2024)
        6.3.2 World Oligonucleotides Market Size by Application (2025-2030)
        6.3.3 World Oligonucleotides Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Integrated DNA Technologies
        7.1.1 Integrated DNA Technologies Details
        7.1.2 Integrated DNA Technologies Major Business
        7.1.3 Integrated DNA Technologies Oligonucleotides Product and Services
        7.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Integrated DNA Technologies Recent Developments/Updates
        7.1.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
    7.2 Agilent
        7.2.1 Agilent Details
        7.2.2 Agilent Major Business
        7.2.3 Agilent Oligonucleotides Product and Services
        7.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Agilent Recent Developments/Updates
        7.2.6 Agilent Competitive Strengths & Weaknesses
    7.3 Sigma-aldrich
        7.3.1 Sigma-aldrich Details
        7.3.2 Sigma-aldrich Major Business
        7.3.3 Sigma-aldrich Oligonucleotides Product and Services
        7.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Sigma-aldrich Recent Developments/Updates
        7.3.6 Sigma-aldrich Competitive Strengths & Weaknesses
    7.4 Eurofins Genomics
        7.4.1 Eurofins Genomics Details
        7.4.2 Eurofins Genomics Major Business
        7.4.3 Eurofins Genomics Oligonucleotides Product and Services
        7.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Eurofins Genomics Recent Developments/Updates
        7.4.6 Eurofins Genomics Competitive Strengths & Weaknesses
    7.5 L.G.C Biosearch Technologies
        7.5.1 L.G.C Biosearch Technologies Details
        7.5.2 L.G.C Biosearch Technologies Major Business
        7.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Services
        7.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 L.G.C Biosearch Technologies Recent Developments/Updates
        7.5.6 L.G.C Biosearch Technologies Competitive Strengths & Weaknesses
    7.6 Eurogentec S.A
        7.6.1 Eurogentec S.A Details
        7.6.2 Eurogentec S.A Major Business
        7.6.3 Eurogentec S.A Oligonucleotides Product and Services
        7.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Eurogentec S.A Recent Developments/Updates
        7.6.6 Eurogentec S.A Competitive Strengths & Weaknesses
    7.7 Nitto Denko Avecia Inc
        7.7.1 Nitto Denko Avecia Inc Details
        7.7.2 Nitto Denko Avecia Inc Major Business
        7.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Services
        7.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Nitto Denko Avecia Inc Recent Developments/Updates
        7.7.6 Nitto Denko Avecia Inc Competitive Strengths & Weaknesses
    7.8 GenScript
        7.8.1 GenScript Details
        7.8.2 GenScript Major Business
        7.8.3 GenScript Oligonucleotides Product and Services
        7.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 GenScript Recent Developments/Updates
        7.8.6 GenScript Competitive Strengths & Weaknesses
    7.9 BBI Life Sciences
        7.9.1 BBI Life Sciences Details
        7.9.2 BBI Life Sciences Major Business
        7.9.3 BBI Life Sciences Oligonucleotides Product and Services
        7.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 BBI Life Sciences Recent Developments/Updates
        7.9.6 BBI Life Sciences Competitive Strengths & Weaknesses
    7.10 GeneDesign
        7.10.1 GeneDesign Details
        7.10.2 GeneDesign Major Business
        7.10.3 GeneDesign Oligonucleotides Product and Services
        7.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 GeneDesign Recent Developments/Updates
        7.10.6 GeneDesign Competitive Strengths & Weaknesses
    7.11 TriLink BioTechnologies
        7.11.1 TriLink BioTechnologies Details
        7.11.2 TriLink BioTechnologies Major Business
        7.11.3 TriLink BioTechnologies Oligonucleotides Product and Services
        7.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 TriLink BioTechnologies Recent Developments/Updates
        7.11.6 TriLink BioTechnologies Competitive Strengths & Weaknesses
    7.12 SGS DNA
        7.12.1 SGS DNA Details
        7.12.2 SGS DNA Major Business
        7.12.3 SGS DNA Oligonucleotides Product and Services
        7.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 SGS DNA Recent Developments/Updates
        7.12.6 SGS DNA Competitive Strengths & Weaknesses
    7.13 LC Sciences
        7.13.1 LC Sciences Details
        7.13.2 LC Sciences Major Business
        7.13.3 LC Sciences Oligonucleotides Product and Services
        7.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 LC Sciences Recent Developments/Updates
        7.13.6 LC Sciences Competitive Strengths & Weaknesses
    7.14 Twist Bioscience
        7.14.1 Twist Bioscience Details
        7.14.2 Twist Bioscience Major Business
        7.14.3 Twist Bioscience Oligonucleotides Product and Services
        7.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Twist Bioscience Recent Developments/Updates
        7.14.6 Twist Bioscience Competitive Strengths & Weaknesses
    7.15 Creative Biogene
        7.15.1 Creative Biogene Details
        7.15.2 Creative Biogene Major Business
        7.15.3 Creative Biogene Oligonucleotides Product and Services
        7.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Creative Biogene Recent Developments/Updates
        7.15.6 Creative Biogene Competitive Strengths & Weaknesses
    7.16 General Biosystems
        7.16.1 General Biosystems Details
        7.16.2 General Biosystems Major Business
        7.16.3 General Biosystems Oligonucleotides Product and Services
        7.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 General Biosystems Recent Developments/Updates
        7.16.6 General Biosystems Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oligonucleotides Industry Chain
    8.2 Oligonucleotides Upstream Analysis
    8.3 Oligonucleotides Midstream Analysis
    8.4 Oligonucleotides Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oligonucleotides Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Oligonucleotides Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Oligonucleotides Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Oligonucleotides Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Oligonucleotides Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oligonucleotides Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Oligonucleotides Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Oligonucleotides Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Oligonucleotides Players in 2023
    Table 12. World Oligonucleotides Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Oligonucleotides Company Evaluation Quadrant
    Table 14. Head Office of Key Oligonucleotides Player
    Table 15. Oligonucleotides Market: Company Product Type Footprint
    Table 16. Oligonucleotides Market: Company Product Application Footprint
    Table 17. Oligonucleotides Mergers & Acquisitions Activity
    Table 18. United States VS China Oligonucleotides Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Oligonucleotides Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Oligonucleotides Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Oligonucleotides Revenue Market Share (2019-2024)
    Table 23. China Based Oligonucleotides Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Oligonucleotides Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Oligonucleotides Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oligonucleotides Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Oligonucleotides Revenue Market Share (2019-2024)
    Table 29. World Oligonucleotides Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Oligonucleotides Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Oligonucleotides Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Oligonucleotides Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Oligonucleotides Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Oligonucleotides Market Size by Application (2025-2030) & (USD Million)
    Table 35. Integrated DNA Technologies Basic Information, Area Served and Competitors
    Table 36. Integrated DNA Technologies Major Business
    Table 37. Integrated DNA Technologies Oligonucleotides Product and Services
    Table 38. Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Integrated DNA Technologies Recent Developments/Updates
    Table 40. Integrated DNA Technologies Competitive Strengths & Weaknesses
    Table 41. Agilent Basic Information, Area Served and Competitors
    Table 42. Agilent Major Business
    Table 43. Agilent Oligonucleotides Product and Services
    Table 44. Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Agilent Recent Developments/Updates
    Table 46. Agilent Competitive Strengths & Weaknesses
    Table 47. Sigma-aldrich Basic Information, Area Served and Competitors
    Table 48. Sigma-aldrich Major Business
    Table 49. Sigma-aldrich Oligonucleotides Product and Services
    Table 50. Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Sigma-aldrich Recent Developments/Updates
    Table 52. Sigma-aldrich Competitive Strengths & Weaknesses
    Table 53. Eurofins Genomics Basic Information, Area Served and Competitors
    Table 54. Eurofins Genomics Major Business
    Table 55. Eurofins Genomics Oligonucleotides Product and Services
    Table 56. Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Eurofins Genomics Recent Developments/Updates
    Table 58. Eurofins Genomics Competitive Strengths & Weaknesses
    Table 59. L.G.C Biosearch Technologies Basic Information, Area Served and Competitors
    Table 60. L.G.C Biosearch Technologies Major Business
    Table 61. L.G.C Biosearch Technologies Oligonucleotides Product and Services
    Table 62. L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. L.G.C Biosearch Technologies Recent Developments/Updates
    Table 64. L.G.C Biosearch Technologies Competitive Strengths & Weaknesses
    Table 65. Eurogentec S.A Basic Information, Area Served and Competitors
    Table 66. Eurogentec S.A Major Business
    Table 67. Eurogentec S.A Oligonucleotides Product and Services
    Table 68. Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Eurogentec S.A Recent Developments/Updates
    Table 70. Eurogentec S.A Competitive Strengths & Weaknesses
    Table 71. Nitto Denko Avecia Inc Basic Information, Area Served and Competitors
    Table 72. Nitto Denko Avecia Inc Major Business
    Table 73. Nitto Denko Avecia Inc Oligonucleotides Product and Services
    Table 74. Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Nitto Denko Avecia Inc Recent Developments/Updates
    Table 76. Nitto Denko Avecia Inc Competitive Strengths & Weaknesses
    Table 77. GenScript Basic Information, Area Served and Competitors
    Table 78. GenScript Major Business
    Table 79. GenScript Oligonucleotides Product and Services
    Table 80. GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. GenScript Recent Developments/Updates
    Table 82. GenScript Competitive Strengths & Weaknesses
    Table 83. BBI Life Sciences Basic Information, Area Served and Competitors
    Table 84. BBI Life Sciences Major Business
    Table 85. BBI Life Sciences Oligonucleotides Product and Services
    Table 86. BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. BBI Life Sciences Recent Developments/Updates
    Table 88. BBI Life Sciences Competitive Strengths & Weaknesses
    Table 89. GeneDesign Basic Information, Area Served and Competitors
    Table 90. GeneDesign Major Business
    Table 91. GeneDesign Oligonucleotides Product and Services
    Table 92. GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. GeneDesign Recent Developments/Updates
    Table 94. GeneDesign Competitive Strengths & Weaknesses
    Table 95. TriLink BioTechnologies Basic Information, Area Served and Competitors
    Table 96. TriLink BioTechnologies Major Business
    Table 97. TriLink BioTechnologies Oligonucleotides Product and Services
    Table 98. TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. TriLink BioTechnologies Recent Developments/Updates
    Table 100. TriLink BioTechnologies Competitive Strengths & Weaknesses
    Table 101. SGS DNA Basic Information, Area Served and Competitors
    Table 102. SGS DNA Major Business
    Table 103. SGS DNA Oligonucleotides Product and Services
    Table 104. SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. SGS DNA Recent Developments/Updates
    Table 106. SGS DNA Competitive Strengths & Weaknesses
    Table 107. LC Sciences Basic Information, Area Served and Competitors
    Table 108. LC Sciences Major Business
    Table 109. LC Sciences Oligonucleotides Product and Services
    Table 110. LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. LC Sciences Recent Developments/Updates
    Table 112. LC Sciences Competitive Strengths & Weaknesses
    Table 113. Twist Bioscience Basic Information, Area Served and Competitors
    Table 114. Twist Bioscience Major Business
    Table 115. Twist Bioscience Oligonucleotides Product and Services
    Table 116. Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Twist Bioscience Recent Developments/Updates
    Table 118. Twist Bioscience Competitive Strengths & Weaknesses
    Table 119. Creative Biogene Basic Information, Area Served and Competitors
    Table 120. Creative Biogene Major Business
    Table 121. Creative Biogene Oligonucleotides Product and Services
    Table 122. Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Creative Biogene Recent Developments/Updates
    Table 124. General Biosystems Basic Information, Area Served and Competitors
    Table 125. General Biosystems Major Business
    Table 126. General Biosystems Oligonucleotides Product and Services
    Table 127. General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 128. Global Key Players of Oligonucleotides Upstream (Raw Materials)
    Table 129. Oligonucleotides Typical Customers
List of Figure
    Figure 1. Oligonucleotides Picture
    Figure 2. World Oligonucleotides Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Oligonucleotides Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Oligonucleotides Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oligonucleotides Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Oligonucleotides Revenue (2019-2030) & (USD Million)
    Figure 13. Oligonucleotides Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Oligonucleotides by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oligonucleotides Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oligonucleotides Markets in 2023
    Figure 27. United States VS China: Oligonucleotides Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Oligonucleotides Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Oligonucleotides Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Oligonucleotides Market Size Market Share by Type in 2023
    Figure 31. DNA Oligos
    Figure 32. RNA Oligos
    Figure 33. World Oligonucleotides Market Size Market Share by Type (2019-2030)
    Figure 34. World Oligonucleotides Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Oligonucleotides Market Size Market Share by Application in 2023
    Figure 36. Pharmaceutical
    Figure 37. Research
    Figure 38. Diagnostic
    Figure 39. Oligonucleotides Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems